Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 6;8(2):e000550. doi: 10.1136/jitc-2020-000550

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Clinicopathological characteristics associated with TMBRB in immunotherapy prediction. Evaluation of TMBRB and various clinicopathological characteristics. (A) The p value of each clinical characteristic and TMBRB in two-variable analysis by Cox regression and the log-rank p value of its model for OS and PFS. (B) Hazard rates of TMBRB and clinical characteristics in each two-variable model. ECOG PS, Eastern Cooperative Oncology Group performance status; OS, overall survival; PFS, progression-free survival; TMBRB, tumor mutational burden radiomic biomarker.